Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$156.23−1.49 (-0.94%)
Close on Nov 18, 2026Market cap $6.15BP/E –Yield –
Belite Bio shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 34M, up 9.8% from the year before. The highest annual figure on record is 34M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34M | +9.8% |
| FY2024 | Dec 31, 2024 | 31M | +14.8% |
| FY2023 | Dec 31, 2023 | 27M | +33.1% |
| FY2022 | Dec 31, 2022 | 20M | +108.7% |
| FY2021 | Dec 31, 2021 | 10M | +8.9% |
| FY2020 | Dec 31, 2020 | 9M | – |
See a number that looks wrong?